These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23221339)

  • 1. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.
    Staser K; Park SJ; Rhodes SD; Zeng Y; He YZ; Shew MA; Gehlhausen JR; Cerabona D; Menon K; Chen S; Sun Z; Yuan J; Ingram DA; Nalepa G; Yang FC; Clapp DW
    J Clin Invest; 2013 Jan; 123(1):329-34. PubMed ID: 23221339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
    Chang T; Krisman K; Theobald EH; Xu J; Akutagawa J; Lauchle JO; Kogan S; Braun BS; Shannon K
    J Clin Invest; 2013 Jan; 123(1):335-9. PubMed ID: 23221337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.
    Wiesner SM; Geurts JL; Diers MD; Bergerson RJ; Hasz DE; Morgan KJ; Largaespada DA
    Am J Hematol; 2011 Jul; 86(7):579-85. PubMed ID: 21681782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
    de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
    J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1.
    Mund JA; Park S; Smith AE; He Y; Jiang L; Hawley E; Roberson MJ; Mitchell DK; Abu-Sultanah M; Yuan J; Bessler WK; Sandusky G; Chen S; Zhang C; Rhodes SD; Clapp DW
    J Biol Chem; 2020 Jul; 295(29):9948-9958. PubMed ID: 32471868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.
    Stansfield BK; Bessler WK; Mali R; Mund JA; Downing BD; Kapur R; Ingram DA
    Am J Pathol; 2014 Jan; 184(1):79-85. PubMed ID: 24211110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
    Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
    Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
    Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
    Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
    Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
    Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
    Kim A; Morgan K; Hasz DE; Wiesner SM; Lauchle JO; Geurts JL; Diers MD; Le DT; Kogan SC; Parada LF; Shannon K; Largaespada DA
    Blood; 2007 Feb; 109(4):1687-91. PubMed ID: 17090653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK Signaling Is Essential for Macrophage Development.
    Richardson ET; Shukla S; Nagy N; Boom WH; Beck RC; Zhou L; Landreth GE; Harding CV
    PLoS One; 2015; 10(10):e0140064. PubMed ID: 26445168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
    Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
    Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity.
    Wang W; Li X; Qin X; Miao Y; Zhang Y; Li S; Yao R; Yang Y; Yu L; Zhu H; Song L; Mao S; Wang X; Chen J; Feng H; Li Y
    Br J Haematol; 2023 Jul; 202(2):328-343. PubMed ID: 37144690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.
    Wang Y; Kim E; Wang X; Novitch BG; Yoshikawa K; Chang LS; Zhu Y
    Cell; 2012 Aug; 150(4):816-30. PubMed ID: 22901811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by
    Perrin S; Protic S; Bretegnier V; Laurendeau I; de Lageneste OD; Panara N; Ruckebusch O; Luka M; Masson C; Maillard T; Coulpier F; Pannier S; Wicart P; Hadj-Rabia S; Radomska KJ; Zarhrate M; Ménager M; Vidaud D; Topilko P; Parfait B; Colnot C
    Sci Transl Med; 2024 Jun; 16(753):eadj1597. PubMed ID: 38924432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nf1 and Gmcsf interact in myeloid leukemogenesis.
    Birnbaum RA; O'Marcaigh A; Wardak Z; Zhang YY; Dranoff G; Jacks T; Clapp DW; Shannon KM
    Mol Cell; 2000 Jan; 5(1):189-95. PubMed ID: 10678181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1.
    Zhu C; Saberwal G; Lu Y; Platanias LC; Eklund EA
    J Biol Chem; 2004 Dec; 279(49):50874-85. PubMed ID: 15371411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK inhibition exerts temporal and myeloid cell-specific effects in the pathogenesis of neurofibromatosis type 1 arteriopathy.
    Tritz R; Hudson FZ; Harris V; Ghoshal P; Singla B; Lin H; Csanyi G; Stansfield BK
    Sci Rep; 2021 Dec; 11(1):24345. PubMed ID: 34934133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.